In vitro properties and experimental pathogenic effect of three strains of feline immunodeficiency viruses (FIV) isolated from cats with terminal disease.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 1377438)

Published in Vet Microbiol on April 01, 1992

Authors

A Moraillon1, F Barré-Sinoussi, A Parodi, R Moraillon, C Dauguet

Author Affiliations

1: Institut National de la Recherche Agronomique, Laboratoire d'Epidémiologie Virale, Maisons Alfort, France.

Articles by these authors

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science (1983) 43.61

Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science (1984) 10.38

Isolation of a new human retrovirus from West African patients with AIDS. Science (1986) 7.97

Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat Med (1998) 4.92

HIV-1 reverse transcriptase specifically interacts with the anticodon domain of its cognate primer tRNA. EMBO J (1989) 4.73

Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1. J Mol Biol (1990) 4.38

Adaptation of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines. Science (1984) 4.02

A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. J Virol (1998) 3.65

Inactivation of lymphadenopathy-associated virus by heat, gamma rays, and ultraviolet light. Lancet (1985) 3.27

Mosaic genome structure of simian immunodeficiency virus from west African green monkeys. EMBO J (1994) 3.19

Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity. J Virol (1995) 2.45

Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther (2009) 2.41

Isolation of new lymphotropic retrovirus from two siblings with haemophilia B, one with AIDS. Lancet (1984) 2.32

Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res Hum Retroviruses (1993) 2.29

Identification and antigenicity of the major envelope glycoprotein of lymphadenopathy-associated virus. Virology (1985) 2.23

Molecular cloning of lymphadenopathy-associated virus. Nature (1985) 2.22

Diversity of V3 region sequences of human immunodeficiency viruses type 1 from the central African Republic. AIDS Res Hum Retroviruses (1993) 2.22

Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc Natl Acad Sci U S A (1994) 2.21

Inactivation of lymphadenopathy associated virus by chemical disinfectants. Lancet (1984) 2.19

Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J Cell Biol (1995) 2.12

Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein. Vaccine (2000) 1.97

Wild Mandrillus sphinx are carriers of two types of lentivirus. J Virol (2001) 1.96

Prevalence of antibodies to lymphadenopathy-associated retrovirus in African patients with AIDS. Science (1984) 1.95

Translocation of antibiotic resistance markers of a plasmid-free Streptococcus pyogenes (group A) strain into different streptococcal hemolysin plasmids. Mol Gen Genet (1984) 1.88

Nucleotide sequence of HIV1-NDK: a highly cytopathic strain of the human immunodeficiency virus. Gene (1989) 1.83

Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2. J Interferon Res (1986) 1.83

Synthetic peptide strategy for the detection of and discrimination among highly divergent primate lentiviruses. AIDS Res Hum Retroviruses (2001) 1.77

Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS. Science (1984) 1.73

Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. AIDS Res Hum Retroviruses (1993) 1.67

Concomitant infection by human herpesvirus 6, HTLV-I, and HIV-2. Lancet (1988) 1.66

Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state. N Engl J Med (1984) 1.51

Diagnosing Pemphigus foliaceus: a retrospective analysis of clinical, histological and immunological criteria. Dermatology (2001) 1.40

Dermatomyofibroma arising in a tattoo. G Ital Dermatol Venereol (2013) 1.38

Emergence of and takeover by hepatitis B virus (HBV) with rearrangements in the pre-S/S and pre-C/C genes during chronic HBV infection. J Virol (1991) 1.35

Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases. Eur J Biochem (1990) 1.33

Serological and virological characterization of HIV-1 group O infection in Cameroon. AIDS (1997) 1.33

Viral load in tissues during the early and chronic phase of non-pathogenic SIVagm infection. J Med Primatol (2004) 1.29

Expression of human CD4 in transgenic mice does not confer sensitivity to human immunodeficiency virus infection. AIDS Res Hum Retroviruses (1992) 1.28

Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation. Virology (1996) 1.26

Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. Dig Liver Dis (2006) 1.26

Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1. J Virol (1995) 1.25

Polymorphism in mitochondrial DNA of several Trichophyton rubrum isolates from clinical specimens. Ann Inst Pasteur Microbiol (1988) 1.23

Cell-to-cell contact results in a selective translocation of maternal human immunodeficiency virus type 1 quasispecies across a trophoblastic barrier by both transcytosis and infection. J Virol (2001) 1.21

Characterization of the main placental cytokine profiles from HIV-1-infected pregnant women treated with anti-retroviral drugs in France. Clin Exp Immunol (2007) 1.19

[Identification of two plasmids isolated from a bacteriocinogenic strain of Clostridium perfringens]. Ann Microbiol (Paris) (1976) 1.17

HepG2 cell binding activities of different hepatitis B virus isolates: inhibitory effect of anti-HBs and anti-preS1(21-47). Virology (1991) 1.15

HIV-1 group N among HIV-1-seropositive individuals in Cameroon. AIDS (2000) 1.12

Transmission of lymphadenopathy-associated virus/human T lymphotropic virus type III in sexual partners. Seropositivity does not predict infectivity in all cases. Am J Med (1986) 1.11

The evolutionary rate of nonpathogenic simian immunodeficiency virus (SIVagm) is in agreement with a rapid and continuous replication in vivo. Virology (1996) 1.11

Detection and titration of neutralizing antibodies to HIV using an inhibition of the cytopathic effect of the virus on MT4 cells. J Virol Methods (1987) 1.11

Hepatitis B defective virus with rearrangements in the preS gene during chronic HBV infection. Virology (1991) 1.10

Selection of maternal human immunodeficiency virus type 1 variants in human placenta. European Network for In Utero Transmission of HIV-1. J Infect Dis (1999) 1.09

In vitro infection of human hepatoma (HepG2) cells with hepatitis B virus. J Virol (1990) 1.09

Posttransplant de novo donor-specific hla antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection. Am J Transplant (2012) 1.07

Immunolocalization of UDP-glucose:glycoprotein glucosyltransferase indicates involvement of pre-Golgi intermediates in protein quality control. Proc Natl Acad Sci U S A (2001) 1.06

[Demonstration of an engagement process towards cell death by apoptosis in lymphocytes of HIV infected patients]. C R Acad Sci III (1991) 1.06

A "sentinel" technique for monitoring viral aerosol contamination. J Infect Dis (1991) 1.06

Inhibition of reverse transcriptase activity by a flavonoid compound, 5,6,7-trihydroxyflavone. Biochem Biophys Res Commun (1989) 1.05

Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis. Br J Dermatol (2006) 1.05

The Parodi-Irgens feline sarcoma virus and simian sarcoma virus have homologous oncogenes, but in different contexts of the viral genomes. J Virol (1983) 1.05

Entry and survival of Leishmania amazonensis amastigotes within phagolysosome-like vacuoles that shelter Coxiella burnetii in Chinese hamster ovary cells. Infect Immun (1995) 1.04

Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth. Aliment Pharmacol Ther (2010) 1.04

Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults. Clin Vaccine Immunol (2007) 1.03

Predominance of CCR5-dependent HIV-1 subtype E isolates in Cambodia. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 1.03

Flushing in rosacea: an experimental approach. Arch Dermatol Res (1980) 1.02

Human immunodeficiency virus induces a dual regulation of Bcl-2, resulting in persistent infection of CD4(+) T- or monocytic cell lines. J Virol (1998) 1.02

Two subpopulations of human triple-negative thymic cells are susceptible to infection by human immunodeficiency virus type 1 in vitro. J Virol (1994) 1.01

Thymocyte-thymic epithelial cell interaction leads to high-level replication of human immunodeficiency virus exclusively in mature CD4(+) CD8(-) CD3(+) thymocytes: a critical role for tumor necrosis factor and interleukin-7. J Virol (1999) 1.01

Genital infection of female chimpanzees with human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (1998) 1.01

Purpura due to ethanol. N Engl J Med (1990) 1.00

Frequent substitution polymorphisms in African green monkey CCR5 cluster at critical sites for infections by simian immunodeficiency virus SIVagm, implying ancient virus-host coevolution. J Virol (2001) 1.00

Variable expression of preS1 antigen in serum during chronic hepatitis B virus infection: an accurate marker for the level of hepatitis B virus replication. Hepatology (1990) 0.99

Fetal spine ossification: the gender and individual differences illustrated by ultrasonography. Ultrasound Med Biol (2005) 0.98

Antenatal HIV prevalence in Yaounde, Cameroon. Int J STD AIDS (1998) 0.98

SIVcpz from a naturally infected Cameroonian chimpanzee: biological and genetic comparison with HIV-1 N. J Med Primatol (2000) 0.97

Reversion of a polymerase-defective integrated HIV-1 genome. AIDS Res Hum Retroviruses (1993) 0.96

Single nucleotide polymorphisms in the promoter regions of Foxp3 and ICOSLG genes are associated with Alopecia areata. Clin Exp Med (2012) 0.96

Passive immunotherapy in AIDS: a double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency virus 1 antibodies vs. transfusions of seronegative plasma. Proc Natl Acad Sci U S A (1995) 0.95

Transcription of polyoma virus DNA in vitro. III. Localization of calf thymus RNA polymerase II binding sites. J Mol Biol (1978) 0.95

High-level replication of human immunodeficiency virus in thymocytes requires NF-kappaB activation through interaction with thymic epithelial cells. J Virol (1999) 0.95

Increase of HIV-1 subtype A in Central African Republic. J Acquir Immune Defic Syndr (1999) 0.95

Coreceptor usage of HIV-1 isolates representing different genetic subtypes obtained from pregnant Cameroonian women. European Network for In Utero Transmission of HIV-1. J Acquir Immune Defic Syndr (2000) 0.93

Endonucleolytic cleavage of polyoma virus DNA: general properties and site specificity of the virion-associated endonuclease. Cold Spring Harb Symp Quant Biol (1975) 0.93

Induction and modulation of acute-phase response by protein malnutrition in rats: comparative effect of systemic and localized inflammation on interleukin-6 and acute-phase protein synthesis. J Nutr (1998) 0.93

Cell-free HIV type 1 infection is restricted in the human trophoblast choriocarcinoma BeWo cell line, even with expression of CD4, CXCR4 and CCR5. AIDS Res Hum Retroviruses (2003) 0.93

Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients. J Intern Med (2005) 0.93

Erythema gyratum repens is not an obligate paraneoplastic disease: a systematic review of the literature and personal experience. J Eur Acad Dermatol Venereol (2012) 0.93

Replication of the human immunodeficiency virus 1 and impaired differentiation of T cells after in vitro infection of bone marrow immature T cells. J Clin Invest (1989) 0.93

Genetically related human immunodeficiency virus type 1 in three adults of a family with no identified risk factor for intrafamilial transmission. J Virol (1998) 0.92

Universal inherited melanodyschromatosis: a case of melanosis universalis hereditaria? Arch Dermatol (1989) 0.92

Evaluation of the placental environment with a new in vitro model of histocultures of early and term placentae: determination of cytokine and chemokine expression profiles. Placenta (2005) 0.92

HIV type 1 Thai subtype E is predominant in South Vietnam. AIDS Res Hum Retroviruses (1996) 0.91

Gene expression profiling in dermatitis herpetiformis skin lesions. Clin Dev Immunol (2012) 0.90

Five-year follow-up of a cognitive-behavioural lifestyle multidisciplinary programme for childhood obesity outpatient treatment. Eur J Clin Nutr (2007) 0.90

Transcription of SV 40 nucleoprotein complexes in vitro. Biochem Biophys Res Commun (1977) 0.90

A comparative study of proliferation and hepatic differentiation of human adipose-derived stem cells. Cells Tissues Organs (2009) 0.89

Persistent erythema multiforme: report of two new cases and review of literature. J Am Acad Dermatol (1995) 0.89

An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry. Aliment Pharmacol Ther (2005) 0.89